Ledger.Open graph →
SEC Form D · filed September 15, 2025

Swing Therapeutics, Inc

Offering
$3.3M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael Rosenbluth · San Francisco, CAExec · DirectorCorey Mccann · San Francisco, CADirectorZack Lynch · San Francisco, CADirectorAndrew Firlik · San Francisco, CADirectorZack Lynch · San Francisco, CADirectorCorey Mccann · San Francisco, CADirectorAndrew Firlik · San Francisco, CADirectorMichael Rosenbluth · San Francisco, CAExec · DirectorMatt Gray · Dallas, TXExec · DirectorBenjamin F. Seidlich · Baltimore, CADirectorCyrus De Weck · London, United KingdomDirectorBal E. Bhullar · Kelowna, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗